Vanguard Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Vanguard Group’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-146,381	Closed	-$3.71M	–	4205
2019 Q1	$3.71M	Buy	+146,381	New	+$2.59M	﹤0.01%	3246

Vanguard Group's NITE Position: Q2 2019 in Review

Vanguard Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 146,381 shares — an estimated $3.71M sold.

Vanguard Group first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $3.71M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Vanguard Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Vanguard Group sold 146,381 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $3.71M.
Vanguard Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Vanguard Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $3.71M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.